Delivery Order SPE2DB22D1103-SPE2DB24FTDZ8
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $143,356.00 firm fixed price delivery order is for the supply of MENQUADFI VIAL 0.5ML, a pharmaceutical product. The contract performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order was not...
- This is a firm fixed price delivery order worth $108,374.22, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a global pharmaceutical sourcing and distribution company. The order is for the supply of MENQUADFI VIAL 0.5ML, a pharmaceutical product. No set-aside designation was used. AmerisourceBergen Drug Corp is a prime contractor that has received numerous federal contracts from DLA Troop Support Medical to provide...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The $142,619.35 firm fixed price delivery order is for the supply of MENQUADFI VIAL 0.5ML pharmaceuticals. As a prime contractor, Amerisourcebergen Drug Corp has provided a range of pharmaceutical products and medical supplies to support DLA Troop Support Medical...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4563276138 MENQUADFI VIAL 0.5ML. The potential value of the contract is $1,404.96. This delivery order was issued under Amerisourcebergen's existing contract to provide pharmaceuticals, medical supplies, and related distribution services to DLA Troop Support Medical facilities. Amerisourcebergen has a history of supporting DLA...
- This federal contract award is a $107,662.62 firm fixed price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The award is for the supply of MENQUADFI VIAL 0.5ML pharmaceutical products, with a completion date of November 29, 2022. The contract has no set-aside designation. AmerisourceBergen Drug Corp has held numerous prior contracts with DLA to provide...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract, valued at $2,809.92, is for the delivery of MENQUADFI VIAL 0.5ML pharmaceutical products to Conshohocken, Pennsylvania. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp serves as the prime contractor and has previously held other indefinite...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of MENQUADFI VIAL 0.5ML pharmaceuticals, with a potential value of $2,107.44. The award has a completion date of December 27, 2023, and there is no set-aside designation mentioned. Amerisourcebergen Drug Corp, through its Corporate Office division, has a history of providing...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of MENQUADFI VIAL 0.5ML medical products. The award, valued at $7,024.80, is a firm-fixed price delivery order that has an ultimate completion date of August 19, 2024. Amerisourcebergen Drug Corp's Corporate Office Division is the prime contractor, and there is no indication of any subcontractors. This delivery order is likely part of a...
- Amerisourcebergen Drug Corp has been awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) Troop Support Medical worth $1,391.76 to supply 4562597830 MENQUADFI VIAL 0.5ML. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania, with all supplies to be delivered by October 26, 2023. No set-aside designation was applied to this order, which was issued against an existing indefinite-delivery contract between Amerisourcebergen and...
- Amerisourcebergen Drug Corp has received a $3,131.46 firm fixed price delivery order from the Defense Logistics Agency Troop Support Medical to supply 4562868893 MENQUADFI VIAL 0.5ML. The delivery order was awarded on November 21, 2023 against an indefinite delivery contract held by Amerisourcebergen, with performance required by November 22, 2023 at its Conshohocken, Pennsylvania facility. No set-aside designation was applied to this award to supply pharmaceutical products in support of DLA...
- SPE2DB22D1103Indefinite Delivery Contract
- SPE2DB22D1103-SPE2DB24FTDZ8Delivery Order
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The $1,756.20 order is for the supply of MENQUADFI VIAL 0.5ML, a pharmaceutical product. The award does not have a set-aside designation and the place of performance is Amerisourcebergen's corporate office in Conshohocken, Pennsylvania. Amerisourcebergen Drug Corp is an experienced federal contractor, having received numerous awards from DLA Troop Support Medical to provide pharmaceuticals, medical supplies, and related distribution services in support of military treatment programs and facilities. The company also holds an indefinite delivery contract with the Department of Justice Federal Bureau of Investigation to provide medical supplies and prescription medications.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 1/18/24 |